Israel -
Hebrew -
Ministry of Health
בוקולאם 2.5 מ"ג
neopharm cure (2005) ltd - midazolam as hydrochloride 2.5 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.
Israel -
Hebrew -
Ministry of Health
בוקולאם 5 מ"ג
neopharm cure (2005) ltd - midazolam as hydrochloride 5 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.
Israel -
Hebrew -
Ministry of Health
בוקולאם 7.5 מ"ג
neopharm cure (2005) ltd - midazolam as hydrochloride 7.5 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.
Israel -
Hebrew -
Ministry of Health
בוקולאם 10 מ"ג
neopharm cure (2005) ltd - midazolam as hydrochloride 10 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available